Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/valsartan in adults with non-obstructive hypertrophic cardiomyopathy
2019-003098-24Phase 2Completed
- Sponsor
- Novartis
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hypertrophic cardiomyopathy (HCM) comparing Sacubitril/valsartan with Placebo (2 arms). Primary endpoint: Change from baseline in peak VO2. Started Nov 2019; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on 2019-003098-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-003098-24.